Patents by Inventor Kazue Natori

Kazue Natori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of evaluating quality of miRNA derived from body fluid
    Patent number: 11408027
    Abstract: A method of evaluating quality of miRNA derived from a body fluid sample includes a measuring step; comparing a measured value(s) of the abundance(s) of the one or more reference miRNAs in a body fluid sample or a representative value thereof to a measured value(s) of the abundance(s) of the one or more reference miRNAs in a standard body fluid sample or a representative value thereof, to obtain a difference(s) or a ratio(s) of the measured value(s) of the abundance(s) of the one or more reference miRNAs or the representative value thereof between the body fluid sample and the standard body fluid sample; and judging the quality of the miRNA derived from the body fluid sample based on the difference(s) or the ratio(s) of the measured value(s) of the abundance(s) of the one or more reference miRNAs or the representative value thereof obtained in the comparing step.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: August 9, 2022
    Assignee: Toray Industries, Inc.
    Inventors: Kazue Natori, Satoko Kozono, Satoshi Kondou
  • METHOD OF EVALUATING QUALITY OF BODY FLUID SPECIMEN
    Publication number: 20210301340
    Abstract: Reference miRNAs whose abundances are altered depending on quality change of a body fluid sample were identified to provide a method of evaluating the quality of a body fluid sample using as indices the abundances of the reference miRNAs in the sample.
    Type: Application
    Filed: July 30, 2019
    Publication date: September 30, 2021
    Inventors: Emi Hoshino, Takashi Serizawa, Kazue Natori
  • METHOD OF EVALUATING QUALITY OF miRNA DERIVED FROM BODY FLUID
    Publication number: 20190048408
    Abstract: A method of evaluating quality of miRNA derived from a body fluid sample includes a measuring step; comparing a measured value(s) of the abundance(s) of the one or more reference miRNAs in a body fluid sample or a representative value thereof to a measured value(s) of the abundance(s) of the one or more reference miRNAs in a standard body fluid sample or a representative value thereof, to obtain a difference(s) or a ratio(s) of the measured value(s) of the abundance(s) of the one or more reference miRNAs or the representative value thereof between the body fluid sample and the standard body fluid sample; and judging the quality of the miRNA derived from the body fluid sample based on the difference(s) or the ratio(s) of the measured value(s) of the abundance(s) of the one or more reference miRNAs or the representative value thereof obtained in the comparing step.
    Type: Application
    Filed: February 21, 2017
    Publication date: February 14, 2019
    Inventors: Kazue Natori, Satoko Kozono, Satoshi Kondou